Opening book details…
Can I read Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method on EtoBox?
Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method by Helleberg, Marie; Jà ̧rgensen, Karin Meinike; Hare, Rasmus Krà ̧ger; Datcu, Raluca; Chowdhary, Anuradha; Arendrup, Maiken Cavling is a Medicine article available to read on EtoBox.
What is Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method about?
Rezafungin (formerly CD101) is a novel echinocandin in clinical development. EUCAST epidemiological cutoff values (ECOFFs) have not yet been established. We determined the in vitro activity of rezafungin and comparators against 1,293 Nordic yeast isolates and 122 Indian Candida auris isolates and established single-center wild-type upper limits (WT-UL). The isolates (19 Candida spp. and 13 other yeast species) were identified using Chromagar; matrix-assisted laser desorption ionization–time of flight (MALDI-TOF); and, when needed, internal transcribed spacer sequencing.
Who reads Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Helleberg, Marie; Jà ̧rgensen, Karin Meinike; Hare, Rasmus Krà ̧ger; Datcu, Raluca; Chowdhary, Anuradha; Arendrup, Maiken Cavling
- Publisher
- American Society for Microbiology (ISSN 0066-4804)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)